EP Patent
EP3125902B1 — Use of negative modulators of gaba receptors containing alpha5 subunits as fast acting antidepressants
Assigned to University of Maryland Baltimore · Expires 2020-09-16 · 6y expired
What this patent protects
Patent listed against Mifeprex.
Drugs covered by this patent
- Mifeprex (MIFEPRISTONE) · Corcept Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.